- Record: found
- Abstract: found
- Article: found
Long non-coding RNAs: From disease code to drug role
review-article
10 October 2020
LncRNAs,
Targeted drug,
Gene therapy,
Small molecules,
Delivery,
ASncmtRNA,
Translational medicine,
Clinical trials,
AD, Alzheimer's disease,
ANRIL, antisense noncoding RNA gene at the INK4 locus,
ASncmtRNA, antisense noncoding mitochondrial RNA,
ASO, antisense oligonucleotide,
BCAR4, breast cancer anti-estrogen resistance 4,
BDNF-AS, brain-derived neurotrophic factor antisense,
CASC9, cancer susceptibility candidate 9,
CDK, cyclin dependent kinase 1,
CHRF, cardiac hypertrophy related factor,
CRISPR, clustered regularly interspaced short palindromic repeats,
DACH1, dachshund homolog 1,
DANCR, differentiation antagonizing non-protein coding RNA,
DKD, diabetic kidney disease,
DPF, diphenyl furan,
EBF3-AS, early B cell factor 3-antisense,
ENE, element for nuclear expression,
Erbb4-IR, Erb-B2 receptor tyrosine kinase 4-immunoreactivity,
FDA, U.S. Food and Drug Administration,
GAPDH, glyceraldehyde-3-phosphate dehydrogenase,
GAS5, growth arrest specific 5,
HISLA, HIF-1α-stabilizing long noncoding RNA,
HOTAIR, HOX transcript antisense intergenic RNA,
HULC, highly upregulated in liver cancer,
lincRNA-p21, long intergenic noncoding RNA p21,
LIPCAR, long intergenic noncoding RNA predicting cardiac remodeling,
LNAs, locked nucleic acids,
lncRNAs, long non-coding RNAs,
MALAT1, metastasis associated lung adenocarcinoma transcript 1,
MEG3, maternally expressed gene 3,
MHRT, myosin heavy chain associated RNA transcripts,
MM, multiple myeloma,
mtlncRNA, mitochondrial long noncoding RNA,
NEAT1, nuclear enriched abundant transcript 1,
NKILA, NF-kappaB interacting lncRNA,
Norad, non-coding RNA activated by DNA damage,
NPs, nanoparticles,
OIP5-AS1, opa-interacting protein 5 antisense transcript 1,
PD, Parkinson's disease,
PEG, polyethylene glycol,
PNAs, peptide nucleic acids,
pHLIP, pH-low insertion peptide,
PTO, phosphorothioate,
PVT1, plasmacytoma variant translocation 1,
RGD, arginine-glycine-aspartic acid peptide,
RISC, RNA-induced silencing complex,
SALRNA1, senescence associated long non-coding RNA 1,
sgRNA, single guide RNA,
siRNAs, small interfering RNAs,
SncmtRNA, sense noncoding mitochondrial RNA,
SNHG1, small nucleolar RNA host gene 1,
THRIL, TNF and HNRNPL related immunoregulatory,
TncRNA, trophoblast-derived noncoding RNA,
TTTY15, testis-specific transcript, Y-linked 15,
TUG1, taurine-upregulated gene 1,
TWIST1, twist family BHLH transcription factor 1,
UCA1, urothelial carcinoma-associated 1,
UTF1, undifferentiated transcription factor 1,
XIST, X-inactive specific transcript
Read this article at
There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.
Abstract
Enormous studies have corroborated that long non-coding RNAs (lncRNAs) extensively participate in crucial physiological processes such as metabolism and immunity, and are closely related to the occurrence and development of tumors, cardiovascular diseases, nervous system disorders, nephropathy, and other diseases. The application of lncRNAs as biomarkers or intervention targets can provide new insights into the diagnosis and treatment of diseases. This paper has focused on the emerging research into lncRNAs as pharmacological targets and has reviewed the transition of lncRNAs from the role of disease coding to acting as drug candidates, including the current status and progress in preclinical research. Cutting-edge strategies for lncRNA modulation have been summarized, including the sources of lncRNA-related drugs, such as genetic technology and small-molecule compounds, and related delivery methods. The current progress of clinical trials of lncRNA-targeting drugs is also discussed. This information will form a latest updated reference for research and development of lncRNA-based drugs.
Graphical abstract
Related collections
Most cited references145
- Record: found
- Abstract: found
- Article: not found
Delivery of siRNA to the mouse brain by systemic injection of targeted exosomes.
Lydia Alvarez-Erviti, Yiqi Seow, HaiFang Yin … (2011)
- Record: found
- Abstract: found
- Article: not found
Molecular mechanisms of long noncoding RNAs.
Kevin Wang, Howard Y. Chang (2011)
Author and article information
lncrnas,targeted drug,gene therapy,small molecules,delivery,asncmtrna,translational medicine,clinical trials,ad, alzheimer's disease,anril, antisense noncoding rna gene at the ink4 locus,asncmtrna, antisense noncoding mitochondrial rna,aso, antisense oligonucleotide,bcar4, breast cancer anti-estrogen resistance 4,bdnf-as, brain-derived neurotrophic factor antisense,casc9, cancer susceptibility candidate 9,cdk, cyclin dependent kinase 1,chrf, cardiac hypertrophy related factor,crispr, clustered regularly interspaced short palindromic repeats,dach1, dachshund homolog 1,dancr, differentiation antagonizing non-protein coding rna,dkd, diabetic kidney disease,dpf, diphenyl furan,ebf3-as, early b cell factor 3-antisense,ene, element for nuclear expression,erbb4-ir, erb-b2 receptor tyrosine kinase 4-immunoreactivity,fda, u.s. food and drug administration,gapdh, glyceraldehyde-3-phosphate dehydrogenase,gas5, growth arrest specific 5,hisla, hif-1α-stabilizing long noncoding rna,hotair, hox transcript antisense intergenic rna,hulc, highly upregulated in liver cancer,lincrna-p21, long intergenic noncoding rna p21,lipcar, long intergenic noncoding rna predicting cardiac remodeling,lnas, locked nucleic acids,lncrnas, long non-coding rnas,malat1, metastasis associated lung adenocarcinoma transcript 1,meg3, maternally expressed gene 3,mhrt, myosin heavy chain associated rna transcripts,mm, multiple myeloma,mtlncrna, mitochondrial long noncoding rna,neat1, nuclear enriched abundant transcript 1,nkila, nf-kappab interacting lncrna,norad, non-coding rna activated by dna damage,nps, nanoparticles,oip5-as1, opa-interacting protein 5 antisense transcript 1,pd, parkinson's disease,peg, polyethylene glycol,pnas, peptide nucleic acids,phlip, ph-low insertion peptide,pto, phosphorothioate,pvt1, plasmacytoma variant translocation 1,rgd, arginine-glycine-aspartic acid peptide,risc, rna-induced silencing complex,salrna1, senescence associated long non-coding rna 1,sgrna, single guide rna,sirnas, small interfering rnas,sncmtrna, sense noncoding mitochondrial rna,snhg1, small nucleolar rna host gene 1,thril, tnf and hnrnpl related immunoregulatory,tncrna, trophoblast-derived noncoding rna,ttty15, testis-specific transcript, y-linked 15,tug1, taurine-upregulated gene 1,twist1, twist family bhlh transcription factor 1,uca1, urothelial carcinoma-associated 1,utf1, undifferentiated transcription factor 1,xist, x-inactive specific transcript
lncrnas, targeted drug, gene therapy, small molecules, delivery, asncmtrna, translational medicine, clinical trials, ad, alzheimer's disease, anril, antisense noncoding rna gene at the ink4 locus, asncmtrna, antisense noncoding mitochondrial rna, aso, antisense oligonucleotide, bcar4, breast cancer anti-estrogen resistance 4, bdnf-as, brain-derived neurotrophic factor antisense, casc9, cancer susceptibility candidate 9, cdk, cyclin dependent kinase 1, chrf, cardiac hypertrophy related factor, crispr, clustered regularly interspaced short palindromic repeats, dach1, dachshund homolog 1, dancr, differentiation antagonizing non-protein coding rna, dkd, diabetic kidney disease, dpf, diphenyl furan, ebf3-as, early b cell factor 3-antisense, ene, element for nuclear expression, erbb4-ir, erb-b2 receptor tyrosine kinase 4-immunoreactivity, fda, u.s. food and drug administration, gapdh, glyceraldehyde-3-phosphate dehydrogenase, gas5, growth arrest specific 5, hisla, hif-1α-stabilizing long noncoding rna, hotair, hox transcript antisense intergenic rna, hulc, highly upregulated in liver cancer, lincrna-p21, long intergenic noncoding rna p21, lipcar, long intergenic noncoding rna predicting cardiac remodeling, lnas, locked nucleic acids, lncrnas, long non-coding rnas, malat1, metastasis associated lung adenocarcinoma transcript 1, meg3, maternally expressed gene 3, mhrt, myosin heavy chain associated rna transcripts, mm, multiple myeloma, mtlncrna, mitochondrial long noncoding rna, neat1, nuclear enriched abundant transcript 1, nkila, nf-kappab interacting lncrna, norad, non-coding rna activated by dna damage, nps, nanoparticles, oip5-as1, opa-interacting protein 5 antisense transcript 1, pd, parkinson's disease, peg, polyethylene glycol, pnas, peptide nucleic acids, phlip, ph-low insertion peptide, pto, phosphorothioate, pvt1, plasmacytoma variant translocation 1, rgd, arginine-glycine-aspartic acid peptide, risc, rna-induced silencing complex, salrna1, senescence associated long non-coding rna 1, sgrna, single guide rna, sirnas, small interfering rnas, sncmtrna, sense noncoding mitochondrial rna, snhg1, small nucleolar rna host gene 1, thril, tnf and hnrnpl related immunoregulatory, tncrna, trophoblast-derived noncoding rna, ttty15, testis-specific transcript, y-linked 15, tug1, taurine-upregulated gene 1, twist1, twist family bhlh transcription factor 1, uca1, urothelial carcinoma-associated 1, utf1, undifferentiated transcription factor 1, xist, x-inactive specific transcript